FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application for Amphetamine Sulfate (amphetamine) from Amneal Pharmaceuticals NY LLC under ANDA211139.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Amphetamine sulfate (amphetamine sulfate)

Snippet

SUPPL AP for AMPHETAMINE SULFATE (AMPHETAMINE)